Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer
Clinical trial NCT02536742 · COMPLETED
Trial details
- NCT number
- NCT02536742
- Sponsor
- ETOP IBCSG Partners Foundation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-30
- Primary completion
- 2020-08-28
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.